Project Grant HT94252310421
- The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
- The Albert Einstein College of Medicine has been awarded a $882,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a novel targeted drug therapy to treat small cell lung cancer (SCLC). The award will support research activities from June 1, 2024 through May 31, 2027. As a highly experienced recipient of federal research grants and contracts, the college has a track record of conducting biomedical research and...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,344,000.00 to the Albert Einstein College of Medicine in Bronx, NY to conduct research titled "Targeting Noncanonical WNT Signaling to Prevent Ewing Sarcoma Metastases in a Novel Zebrafish Model." The award period runs from May 1, 2025 to April 30, 2029. The project aims to investigate innovative treatments for Ewing sarcoma, a rare...
- The Albert Einstein College of Medicine was awarded a $505,122 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to decipher the stemness code for breast cancer metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health...
- The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
- The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
- The U.S. Department of Defense's Defense Health Agency awarded a $672,000 Project Grant to the Albert Einstein College of Medicine in Bronx, NY to support the "MRNA TRANSLATION AND IMMUNE RECOGNITION IN MYC-DRIVEN LYMPHOMA" research project. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives to transform healthcare for military service members and the broader public. The 2-year project,...
- The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- The Defense Health Agency awarded a $462,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Albert Einstein College of Medicine in Bronx, NY. This grant, with a period of performance from January 1, 2025 to December 31, 2026, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on the "Proteomics of Vascular Wall...
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,209,600.00 Project Grant to Albert Einstein College of Medicine in Bronx, New York under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will support a project titled "VALIDATION OF BIOMARKERS OF POST-TRAUMATIC SEIZURES IN AN OPTIMIZED MODEL OF TRAUMATIC BRAIN INJURY" with a completion date of June 30, 2026. Through this funding, Albert Einstein College of...
Albert Einstein College of Medicine (AECOM) was awarded a $672,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on Treatment-Induced Metastasis in Ewing Sarcoma. The two-year grant runs from June 1, 2023 to May 31, 2025 and will support AECOM's investigation into medical solutions for metastatic cancers affecting service members, in line with the program's goals of transforming military and public health through innovative biomedical research. As the prime recipient, AECOM will leverage its expertise in oncology clinical trials and product development to advance understanding of the vulnerabilities of Ewing sarcoma cells and potential avenues for improving patient outcomes and survival rates.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $672.0k | 5/2/23 |